IN-DATE
C2010B: BD Bard TruGuide Coaxial Biopsy Needle for Magnum 20G, 19G x 7.0cm
Photos are for illustration purposes only and may not depict the exact item.
Sign in to add this product to your favorites!
| Price: | $6.00 EACH |
|---|---|
| Quantity: | |
| In Stock: | 3 eaches |
| Status: | expired |
The item listed above is expired and may be used for educational, training, and non-clinical research purposes only. Any product information appearing below, including the product indication statement, pertains to an in date item only.
Additional Details
BD Bard® TruGuide "B" Series Disposable Coaxial Biopsy
- For use with the Bard® Magnum
- Provides a clear path to work through when performing multiple biopsies in the same area
- Engineered compatibility with Bard® Biopsy products enhances efficiency and accuracy
- Sized just one gauge larger than corresponding Bard® Core Tissue Biopsy Needles
- Color-coded depth stops conveniently match the recommended Bard® Biopsy Needle
AccessGUDID Info
- FDA Product Code: FCG
- FDA Product Code Name: Biopsy needle
- GMDN Term Code: 45018
- GMDN Term Name: Needle guide, single-use
- GMDN Term Description: A rigid, non-powered device designed to direct a sharp needle (not included) into its proper course when performing a clinical and/or surgical procedure; the guide itself is not intended for percutaneous access (not a guide-catheter). Dedicated needle guides are available for different procedures such as urethral injections, image-guided (e.g., ultrasound, MRI) transrectal/transperineal prostate biopsy or ablation, endocavity IVF procedures, percutaneous punctures, nerve blocks, electromagnetic device tracking surgery, and stereotactic breast biopsies. Procedural supportive devices (e.g., ultrasound transducer cover/sheath, drape) may be included with the device. This is a single-use device.
Manufacturer
C.R. Bard (a part of BD - Becton, Dickinson and Company) was a global leader in the development and manufacturing of innovative medical technologies. Known for their high-quality products, Bard specialized in solutions for vascular access, urology, oncology, and surgical specialties. Their product portfolio included catheters, biopsy devices, implantable ports, and hernia repair systems, designed to enhance patient care and procedural efficiency. As part of BD, the legacy of C.R. Bard continues to drive advancements in healthcare, delivering trusted solutions that improve outcomes for patients and providers worldwide.
